AquaBounty Technologies (NASDAQ:AQB) Shares Climb 7.8% – Here’s What HappenedDefense World · Oct 11, 2026
AquaBounty Technologies (NASDAQ:AQB) Shares Pass Below 50 Day Moving Average – Here’s WhyDefense World · Sep 18, 2026
AquaBounty Announces Engagement of Colliers as Exclusive Agent for its Ohio PropertyNewsfile Corp · Sep 15, 2026
AquaBounty Technologies Announces Expansion of Strategic Alternatives Review to Include Power Infrastructure Development OpportunitiesNewsfile Corp · Aug 6, 2026AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | – | -$0.26 | |
| May 7, 2026 | – | -$0.20 | |
| Mar 31, 2026 | -$0.52 | -$3.64 | Miss |
| Oct 28, 2025 | -$0.62 | -$0.36 | Beat |
| Aug 5, 2025 | -$0.53 | -$0.87 | Miss |
| May 15, 2025 | -$0.61 | $0.16 | Beat |